Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2010
04/08/2010WO2010039545A2 1,2-benzisothiazolinone and isoindolinone derivatives
04/08/2010WO2010039518A2 Tricyclic carbamate jak inhibitors
04/08/2010WO2010039238A1 Compounds for inflammation and immune-related uses
04/08/2010WO2010039236A1 Compounds for inflammation and immune-related uses
04/08/2010WO2010039079A1 Isoquinolinone derivatives
04/08/2010WO2010038901A1 7-piperidinoalkyl-3,4-dihydroquinolone derivative
04/08/2010WO2010038854A1 1,3,5-triazine derivative, process for producing same, and organic electroluminescent element comprising same as constituent component
04/08/2010WO2010038803A1 2-indoleacrylamide analogue
04/08/2010WO2010038465A1 8-substituted isoquinoline derivative and use thereof
04/08/2010WO2010038081A2 Heterocyclic derivatives and methods of use thereof
04/08/2010WO2010037727A1 Piperazine compounds with herbicidal effect
04/08/2010WO2010037339A1 Aminoquinazoline derivatives and their salts with antineoplastic activity
04/08/2010WO2010018458A3 Phenol derivatives as hif-alpha modulators
04/08/2010WO2010005692A3 Insecticidal cyclic carbonyl amidines
04/08/2010WO2009156090A3 Insecticidal sulfur-derivatized 1-azinylpyrazoles
04/08/2010WO2009053763A8 New non-peptide derivatives as bradykinin b1 antagonists
04/08/2010US20100087652 99.9% By weight of amorphous S-omeprazole magnesium, <0.1% by weight of impurities as determined by liquid chromatography; X-ray powder diffractogram; substantially free of neutral omeprazole; optical purity 94-96% e.e.; anhydrous; industrial scale; materials handling; filterable
04/08/2010US20100087651 New mandelic acid derivatives and their use as thrombin inhibitors
04/08/2010US20100087650 (1r,1'r)-atracurium salts separation process
04/08/2010US20100087489 Phenyl and Benzodioxinyl Substituted Indazoles Derivatives
04/08/2010US20100087488 Physiologically Acceptable Salts of 3-[(2--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
04/08/2010US20100087486 Methods for using tgf-b receptor inhibitors or activin-like kinase (alk) 5 inhibitors a-83-01 and sb-431542 to treat eye disease and wound healing conditions
04/08/2010US20100087485 4-aminopiperidine derivatives
04/08/2010US20100087484 Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands
04/08/2010US20100087479 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels
04/08/2010US20100087466 Novel small molecule dnak inhibitors
04/08/2010US20100087465 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
04/08/2010US20100087464 Protein kinase inhibitors and methods for using thereof
04/08/2010US20100087449 Heteroarylamide pyrimidone compounds
04/08/2010US20100087446 2-substituted indole derivatives as calcium channel blockers
04/08/2010US20100087445 Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders
04/08/2010US20100087444 Imatinib mesylate
04/08/2010US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/08/2010US20100087434 NK-1 and Serotonin Transporter Inhibitors
04/08/2010US20100087432 Pyrrole derivatives having crth2 receptor antagonist activity
04/08/2010US20100087427 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
04/08/2010US20100087360 Heterocycle-substituted benzimidazole derivative
04/08/2010US20100087320 Arylphenyl-substituted cyclic keto-enols
04/08/2010US20100084971 Material for organic electroluminescence device and electroluminescence device employing the same
04/08/2010DE102007021043B4 Alpha-Form von Imatinib Mesylat und Verfahren zu seiner Herstellung Alpha-form of imatinib mesylate and a process for its preparation
04/08/2010CA2739513A1 7-piperidinoalkyl-3,4-dihydroquinolone derivative
04/08/2010CA2739321A1 Compounds for inflammation and immune-related uses
04/08/2010CA2739303A1 Compounds for inflammation and immune-related uses
04/08/2010CA2738828A1 Novel compounds
04/08/2010CA2738827A1 P38 mapk kinase inhibitors
04/08/2010CA2738663A1 Spiro-imidazolone derivatives as glucagon receptor antagonists
04/08/2010CA2738563A1 8-substituted isoquinoline derivatives and the use thereof
04/08/2010CA2738314A1 1,2-benzisothiazolinone and isoindolinone derivatives
04/08/2010CA2737480A1 Novel compounds as calcium channel blockers
04/08/2010CA2737434A1 Isoquinolinone derivatives
04/08/2010CA2736258A1 Tricyclic carbamate jak inhibitors
04/07/2010EP2172559A1 Screening method
04/07/2010EP2172468A1 Benzimidazolone compounds
04/07/2010EP2172467A1 2-(pyridin -2-yl)-pyrimidines and their use for controlling pathogenic fungi
04/07/2010EP2172466A1 2-(pyridin-2-yl)-pyrimidines and use of same to combat hazardous fungi
04/07/2010EP2172465A1 2-(pyridin -2-yl)-pyrimidines and their use for controlling pathogenic fungi
04/07/2010EP2172462A1 Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound, and method for production of isoxazoline compound
04/07/2010EP2172461A1 Di(arylamino)aryl compound
04/07/2010EP2172460A1 Compositions useful as inhibitors of JAK and other protein kinases
04/07/2010EP2172458A1 Pyrazolone derivative
04/07/2010EP2172457A2 Fredericamycin derivatives
04/07/2010EP2172456A1 N-phenyl-methanamine derivative and pest control agent containing the same
04/07/2010EP2172454A1 Benzimidazole derivative
04/07/2010EP2170867A1 Protein kinase inhibitors and methods for using thereof
04/07/2010EP2170866A1 Phthalazine compounds, compositions and methods of use
04/07/2010EP2170864A1 Pyridone gpr119 g protein-coupled receptor agonists
04/07/2010EP2170863A2 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
04/07/2010EP2170862A1 Use of n,n'-bis(1,1-dihydroperfluoro-c3-c5-alkyl)perylene-3,4:9,10-tetracarboxylic diimides
04/07/2010EP2170861A2 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
04/07/2010EP2170860A2 Benzimidazole derivatives
04/07/2010EP2170859A1 Benzimidazole amido derivatives as kinase inhibitors
04/07/2010EP2170848A1 Pyrazinone derivatives and their use in the treatment of lung diseases
04/07/2010EP2170847A2 Substituted piperazines as cb1 antagonists
04/07/2010EP2170846A2 Substituted piperazines as cb1 antagonists
04/07/2010EP2170843A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
04/07/2010EP2170842A1 Protein kinase inhibitors and methods for using thereof
04/07/2010EP2170839A1 Alkynylpyrimidines as tie2 kinase inhibitors
04/07/2010EP2170823A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides
04/07/2010EP2170260A1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres
04/07/2010EP2170066A2 Pesticides and uses thereof
04/07/2010EP2170065A1 Diphenyl substituted alkanes
04/07/2010EP1597250B1 Indolylmaleimide derivatives
04/07/2010EP1590340B1 Inhibitors of histone deacetylase
04/07/2010EP1551829B1 Novel compounds with antibacterial activity
04/07/2010EP1527050B1 Quinoline derivatives and their use as mycobacterial inhibitors
04/07/2010CN1934090B Substituted N-cyclohexyl imidazolinones having an MCH-modulatory effect
04/07/2010CN101691355A Substituted 4-quinolinone compounds and preparation method thereof
04/07/2010CN101691354A Method for chemically synthesizing 2-heteroaryl substituted quinoline derivatives
04/06/2010US7692028 for treating neurological disorders such as epilepsy, neuropathic pain, bipolar disorder or migraine; 2-(2-oxo-4-propyl-1-pyrrolidinyl)butanamide; neuroprotective agent
04/06/2010US7691892 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
04/06/2010US7691886 Benzimidazole derivatives as raf kinase inhibitors
04/06/2010US7691881 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-HT4 receptor agonistic activity
04/06/2010US7691879 Isoquinoline potassium channel inhibitors
04/06/2010US7691870 N-[4-(pyridine-4-yloxy)phenyl]-4-bromo-6-tefluoromethyl-1H-benzimidazole-2-carboxamide; for cancerous cell growth mediated by one or more raf-kinases
04/06/2010US7691866 Anticancer agents
04/06/2010US7691864 Anti-hypertensive composition and methods of treatment
04/06/2010US7691861 Indolymaleimide derivatives
04/06/2010US7691860 Neuropeptide Y receptor antagonists; such as 2-(trans-4-tert-butylsulfonylaminocyclohexyl)-5-(trifluoromethyl)benzimidazole; bulimia, obesity, diabetes
04/06/2010US7691854 Diethyl 2-amino-4-(4-cyanophenyl)-6-methyl-1-(3-methylphenyl)-1,4-dihydro-3,5-pyridine-dicarboxylate; chronic obstructive pulmonary disease, acute coronary syndrome, acute myocardial infarction or development of heart failure
04/06/2010US7691853 Pyrazole compounds useful as protein kinase inhibitors